O’Donnell J TL, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls — United States, 2019–2020. MMWR Morb Mortal Wkly Rep. 2021;70:1740-1746. https://doi.org/10.15585/mmwr.mm7050e3
Article PubMed PubMed Central Google Scholar
Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M. Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019. Int J Drug Policy. 2022:103786. https://doi.org/10.1016/j.drugpo.2022.103786
National Academies of Sciences, Engineering, Medicine. Methadone Treatment for Opioid Use Disorder: Improving Access through Regulatory and Legal Change: Proceedings of a Workshop. The National Academies Press; 2022:180.
Simon C, Vincent L, Coulter A, et al. The Methadone Manifesto: treatment experiences and policy recommendations from methadone patient activists. Am J Public Health. 2022;112(S2):S117-s122. https://doi.org/10.2105/ajph.2021.306665
Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. "It's like 'liquid handcuffs": the effects of take-home dosing policies on methadone maintenance treatment (MMT) patients' lives. Harm Reduct J. 2021;18(1):88. https://doi.org/10.1186/s12954-021-00535-y
Article PubMed PubMed Central Google Scholar
Leppin AL, Montori VM, Gionfriddo MR. Minimally disruptive medicine: a pragmatically comprehensive model for delivering care to patients with multiple chronic conditions. Healthcare (Basel). 2015;3(1):50-63. https://doi.org/10.3390/healthcare3010050
Serrano V, Spencer-Bonilla G, Boehmer KR, Montori VM. Minimally disruptive medicine for patients with diabetes. Curr Diab Rep. 2017;17(11):104. https://doi.org/10.1007/s11892-017-0935-7
Corbett TK, Cummings A, Lee K, et al. Planning and optimising CHAT&PLAN: a conversation-based intervention to promote person-centred care for older people living with multimorbidity. PLoS One. 2020;15(10):e0240516. https://doi.org/10.1371/journal.pone.0240516
Article CAS PubMed PubMed Central Google Scholar
Leppin AL, Gionfriddo MR, Kessler M, et al. Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med. 2014;174(7):1095-107. https://doi.org/10.1001/jamainternmed.2014.1608
Article PubMed PubMed Central Google Scholar
Spencer-Bonilla G, Quiñones AR, Montori VM. Assessing the burden of treatment. J Gen Intern Med. 2017;32(10):1141-1145. https://doi.org/10.1007/s11606-017-4117-8
Article PubMed PubMed Central Google Scholar
Albreht T, Dyakova M, Schellevis FG, Van den Broucke S. Many diseases, one model of care? J Comorb. 2016;6(1):12-20. https://doi.org/10.15256/joc.2016.6.73
Article PubMed PubMed Central Google Scholar
Wieringa TH, Sanchez-Herrera MF, Espinoza NR, Tran VT, Boehmer K. Crafting care that fits: workload and capacity assessments complementing decision aids in implementing shared decision making. J Particip Med. 2020;12(1):e13763. https://doi.org/10.2196/13763
Article PubMed PubMed Central Google Scholar
Taksler GB, Peterse EFP, Willems I, et al. Modeling strategies to optimize cancer screening in USPSTF guideline-noncompliant women. JAMA Oncol. 2021;7(6):885-894. https://doi.org/10.1001/jamaoncol.2021.0952
Article PubMed PubMed Central Google Scholar
Ekstedt M, Kirsebom M, Lindqvist G, et al. Design and development of an eHealth service for collaborative self-management among older adults with chronic diseases: a theory-driven user-centered approach. Int J Environ Res Public Health. 2021;19(1) https://doi.org/10.3390/ijerph19010391
Abu Dabrh AM, Boehmer KR, Shippee N, et al. Minimally disruptive medicine (MDM) in clinical practice: a qualitative case study of the human immunodeficiency virus (HIV) clinic care model. BMC Health Serv Res. 2021;21(1):24. https://doi.org/10.1186/s12913-020-06010-x
Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65(10):1041-51. https://doi.org/10.1016/j.jclinepi.2012.05.005
Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open. 2020;3(2):e1920622-e1920622. https://doi.org/10.1001/jamanetworkopen.2019.20622
21 C.F.R. §1306.07.
42 C.F.R. § 8.12.
Joudrey PJ, Edelman EJ, Wang EA. Methadone for opioid use disorder-decades of effectiveness but still miles away in the US. JAMA Psychiatry. 2020;77(11):1105-1106. https://doi.org/10.1001/jamapsychiatry.2020.1511
Article PubMed PubMed Central Google Scholar
Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatry. 2019;76(9):979-981. https://doi.org/10.1001/jamapsychiatry.2019.0876
Article PubMed PubMed Central Google Scholar
Cohen SM, Weimer MB, Levander XA, Peckham AM, Tetrault JM, Morford KL. Low dose initiation of buprenorphine: a narrative review and practical approach. J Addict Med. 2021;https://doi.org/10.1097/adm.0000000000000945
Sue KL, Cohen S, Tilley J, Yocheved A. A plea from people who use drugs to clinicians: new ways to initiate buprenorphine are urgently needed in the fentanyl era. J Addict Med. 2022;https://doi.org/10.1097/adm.0000000000000952
McNeil R, Small W, Wood E, Kerr T. Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014;105:59-66. https://doi.org/10.1016/j.socscimed.2014.01.010
Article PubMed PubMed Central Google Scholar
van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1-2):23-35. https://doi.org/10.1016/j.drugalcdep.2013.02.018
Krawczyk N, Negron T, Nieto M, Agus D, Fingerhood MI. Overcoming medication stigma in peer recovery: a new paradigm. Subst Abus. 2018;39(4):404-409. https://doi.org/10.1080/08897077.2018.1439798
Article PubMed PubMed Central Google Scholar
McCarty D, Bougatsos C, Chan B, et al. Office-based methadone treatment for opioid use disorder and pharmacy dispensing: a scoping review. Am J Psychiatry. 2021;178(9):804-817. https://doi.org/10.1176/appi.ajp.2021.20101548
Article PubMed PubMed Central Google Scholar
Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: a randomized controlled trial. Jama. 2001;286(14):1724-31. https://doi.org/10.1001/jama.286.14.1724
Article CAS PubMed Google Scholar
Wakeman SE, Lambert E, Kung S, et al. Trends in buprenorphine treatment disparities during the COVID pandemic in Massachusetts. Substance Abuse.2022;43(1):1317-1321. https://doi.org/10.1080/08897077.2022.2095077
Article CAS PubMed Google Scholar
Wakeman SE, Bryant A, Harrison N. Redefining child protection: addressing the harms of structural racism and punitive approaches for birthing people, dyads, and families affected by substance use. Obstetrics & Gynecology. 2022;140(2):167-173. https://doi.org/10.1097/aog.0000000000004786
Andraka-Christou B. Addressing racial and ethnic disparities in the use of medications for opioid use disorder. Health Aff (Millwood). 2021;40(6):920-927. https://doi.org/10.1377/hlthaff.2020.02261
Kariisa M DN, Kumar S, Seth P, Mattson C, Chowdhury F, Jones C. Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep. 2022;71:940–947
Article PubMed PubMed Central Google Scholar
Adams Z KN, Simon R, Sue K, Suen L, Joudrey P. To save lives from opioid overdose deaths, bring methadone into mainstream medicine. Health Affairs Forefront. May 27, 2022. https://doi.org/10.1377/forefront.20220524.911965
Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A call to action: hospitalists' role in addressing substance use disorder. J Hosp Med. 2019;14(3):E1-E4. https://doi.org/10.12788/jhm.3311
Englander H, Davis, J.D. Hospital standards of care for people with substance use disorder. New England J of Med. In Press 2022;
Snyder H, Kalmin MM, Moulin A, et al. Rapid adoption of low-threshold buprenorphine treatment at California emergency departments participating in the CA Bridge program. Ann Emerg Med. 2021;78(6):759-772. https://doi.org/10.1016/j.annemergmed.2021.05.024
Kimmel SD, Rosenmoss S, Bearnot B, et al. Northeast postacute medical facilities disproportionately reject referrals for patients with opioid use disorder. Health Aff (Millwood). 2022;41(3):434-444. https://doi.org/10.1377/hlthaff.2021.01242
Wakeman SE, Rich JD. Addiction treatment within U.S. correctional facilities: bridging the gap between current practice and evidence-based care. J Addict Dis. 2015;34(2-3):220-5. https://doi.org/10.1080/10550887.2015.1059217
Lambdin BH, Bluthenthal RN, Tookes HE, et al. Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States. Drug and Alcohol Dependence. 2022;237:109504. https://doi.org/10.1016/j.drugalcdep.2022.109504
Article CAS PubMed Google Scholar
Gibbons JB, Stuart EA, Saloner B. Methadone on wheels—a new option to expand access to care through mobile units. JAMA Psychiatry. 2022;79(3):187-188. https://doi.org/10.1001/jamapsychiatry.2021.3716
Chan B, Hoffman KA, Bougatsos C, Grusing S, Chou R, McCarty D. Mobile methadone medication units: a brief history, scoping review and research opportunity. J Subst Abuse Treat. 2021;129:108483. https://doi.org/10.1016/j.jsat.2021.108483
Article CAS PubMed PubMed Central Google Scholar
Chan B, Gean E, Arkhipova-Jenkins I, et al. Retention strategies for medications for opioid use disorder in adults: a rapid evidence review. J Addict Med. 2021;15(1):74-84. https://doi.org/10.1097/adm.0000000000000739
Lockard R, Priest KC, Gregg J, Buchheit BM. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19. Subst Abus. 2022;43(1):1150-1157. https://doi.org/10.1080/08897077.2022.2060447
Levander XA, Hoffma
留言 (0)